NIFTY 50
22,828.55 (1.92%)
NIFTY IT
32,740.85 (0.69%)
NIFTY AUTO
20,548.65 (2.03%)
NIFTY FINANCIAL SERVICES
24,555.55 (1.75%)
NIFTY BANK
51,002.35 (1.52%)
NIFTY REALTY
790.15 (1.26%)
NIFTY ENERGY
32,411.10 (2.70%)
NIFTY METAL
8,168.30 (4.09%)
NIFTY FMCG
55,741.10 (0.86%)
NIFTY HEALTH CARE
13,326.65 (1.53%)
NIFTY PHARMA
20,461.90 (2.43%)
NIFTY MEDIA
20,461.90 (2.43%)
Platforms
Mobile Application
Web Trading
Desktop Application
Insights
Research
Videos
Markets
Equity
Derivatives
IPO
Other Markets
Corporate Information
Pricing
Support
Login
Open an Account
Home
Platform
Insights
Research
Markets
Pricing
Support
Login
Open an Account
Trend of Stock Market
A trend is the broad upward or downward movement of a stock's price over time
Forthcoming IPO
Open Issues
Closed Issue
Top Gainers / Losers
52 Weeks High/ Low
Value / Volume Toppers
Get Quotes
Nifty Futures
Top Traded Quantity
Top Traded Value
Derivative Summary
Daily Settlement Price
List Of Underlying
Put Call Ratio
FII Statistics
Most Active Contract
All Index Futures
Top Gainers
Top Losers
Highest In OI
Lowest In OI
Increase In OI
Decrease In OI
Most Active Calls
Most Active Put
Top Gainers
Top Losers
Highest In OI
Lowest In OI
Increase In OI
Decrease In OI
Forthcoming Issues
Open Issues
Closed Issue
World Indices
ADR Prices
MF Investment
FII Investment
Get Quotes
Company Snapshot
Company Background
Board of Directors
Directors Reports
Profit & Loss
Balance Sheet
Quarterly Results
Shareholding Pattern
Key Financial Ratios
Mutual Fund Holdings
Peer Comparison
Technical Chart
Company News
Change Company Name
Alkem Laboratories Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
539523
ISIN Demat
INE540L01014
Book Value
984.46
NSE Symbol
ALKEM
Dividend Yield (%)
0.82
Market Cap (
₹
Cr.)
58,351.90
P/E
26.09
EPS
187.04
Face Value
2
Date
Headline
12-Mar-25
Alkem Laboratories launches generic empagliflozin in India
10-Mar-25
Alkem Laboratories announces appointment of senior management personnel
07-Feb-25
Board of Alkem Laboratories recommends interim dividend
28-Jan-25
Alkem Laboratories announces board meeting date
10-Dec-24
Board of Alkem Laboratories approves transfer of its trade generics biz to Alkem Wellness
07-Nov-24
Alkem Laboratories to conduct board meeting
10-Oct-24
Alkem Laboratories inks licensing agreement with Sonnet
25-Jul-24
Alkem Laboratories to declare Quarterly Result
15-Jul-24
Alkem incorporates WoS named Alixer Nexgen Therapeutics
28-Jun-24
Alkem Laboratories to convene AGM
Prev
1
2
3
Next